SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-10-033480
Filing Date
2010-06-15
Accepted
2010-06-15 12:00:41
Documents
6
Period of Report
2010-06-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v188206_8k.htm 8-K 32248
2 v188206_ex10-1.htm EX-10.1 39301
3 v188206_ex10-2.htm EX-10.2 32047
4 v188206_ex10-3.htm EX-10.3 41836
5 v188206_ex10-4.htm EX-10.4 31994
6 v188206_ex10-5.htm EX-10.5 45954
  Complete submission text file 0001144204-10-033480.txt   225120
Mailing Address 1617 JFK BLVD ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD #660 ONE PENN CENTER PHILADELPHIA PA 19104 2159880080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13441 | Film No.: 10896773
SIC: 2836 Biological Products, (No Diagnostic Substances)